Emcure Pharmaceuticals Limited — Important, 07-11-2024: Financial Result Updates

Emcure Pharmaceuticals reported strong financial results, with a 20.4% year-over-year revenue growth at ₹2,002 crore and a 38.2% increase in profit after tax (PAT) at ₹202 crore. The domestic sales grew by 15.4% and international sales surged by 25%. EBITDA rose by 26.1%, yielding a margin of 20.8%. Significant partnerships and market expansion have contributed positively to its performance. The company continues to focus on operational efficiencies for future growth.